• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Roux-en-Y胃旁路术后继发性甲状旁腺功能亢进的患病率及相关因素:一项荟萃分析。

Prevalence and associated factors of secondary hyperparathyroidism after Roux-en-Y gastric bypass: A meta-analysis.

作者信息

Gao Zhiguang, Liang Yuzhi, Zheng Chao, Wang Zhongchang, Wu Zhenpeng, Li Min, Huang Shifang, Yang Jingge

机构信息

Department of Gastrointestinal Surgery, SSL Central Hospital of Dongguan City, Affiliated Dongguan Shilong People's Hospital of Southern Medical University, Dongguan, China.

Department of Medical Imaging, SSL Central Hospital of Dongguan City, Affiliated Dongguan Shilong People's Hospital of Southern Medical University, Dongguan, China.

出版信息

Obes Rev. 2022 Oct;23(10):e13488. doi: 10.1111/obr.13488. Epub 2022 Jun 15.

DOI:10.1111/obr.13488
PMID:35705105
Abstract

This study aimed to investigate the prevalence and factors associated with secondary hyperparathyroidism (SHPT) after Roux-en-Y gastric bypass (RYGB). We searched PubMed, EMBASE, and CENTRAL for relevant studies using search terms gastric bypass, RYGB and hyperparathyroidism. Thirty-four cohort studies with 4331 patients were incorporated into the final meta-analysis. Overall estimates of the prevalence of SHPT following RYGB were 39%. Subgroup analyses indicated the pooled prevalences of SHPT were 25%, 42%, 48%, and 54% for ≤1 year, >1 and ≤5 years, >5 and ≤10 years, and >10 years, respectively, after RYGB. Meta-regression showed that SHPT occurred was positively related to follow-up durations (p = 0.001). Additionally, SHPT prevalence was higher in studies in which calcium and vitamin D supplementation were considered inadequate than in those which were adequate (p = 0.002). SHPT is highly prevalent in individuals with obesity after RYGB. It seems to progress with time after surgery. Routine calcium and vitamin D supplementation post-RYGB together with targeted treatment of vitamin D deficiency, reasonable adjustment of the doses of supplementation with regular follow-up, and improved patient compliance, as well as long-term screening, are necessary to prevent the development of SHPT.

摘要

本研究旨在调查Roux-en-Y胃旁路术(RYGB)后继发性甲状旁腺功能亢进(SHPT)的患病率及相关因素。我们在PubMed、EMBASE和CENTRAL中检索了使用胃旁路术、RYGB和甲状旁腺功能亢进等检索词的相关研究。34项队列研究共纳入4331例患者,纳入最终的荟萃分析。RYGB术后SHPT患病率的总体估计为39%。亚组分析表明,RYGB术后≤1年、>1年且≤5年、>5年且≤10年以及>10年时SHPT的合并患病率分别为25%、42%、48%和54%。Meta回归显示,SHPT的发生与随访时间呈正相关(p = 0.001)。此外,在钙和维生素D补充被认为不足的研究中,SHPT患病率高于补充充足的研究(p = 0.002)。RYGB术后肥胖个体中SHPT非常普遍。术后似乎会随时间进展。RYGB术后常规补充钙和维生素D,同时针对性治疗维生素D缺乏,定期随访合理调整补充剂量,提高患者依从性,以及进行长期筛查,对于预防SHPT的发生是必要的。

相似文献

1
Prevalence and associated factors of secondary hyperparathyroidism after Roux-en-Y gastric bypass: A meta-analysis.Roux-en-Y胃旁路术后继发性甲状旁腺功能亢进的患病率及相关因素:一项荟萃分析。
Obes Rev. 2022 Oct;23(10):e13488. doi: 10.1111/obr.13488. Epub 2022 Jun 15.
2
High Incidence of Secondary Hyperparathyroidism in Bariatric Patients: Comparing Different Procedures.肥胖症患者继发性甲状旁腺功能亢进的高发病率:不同手术方式的比较
Obes Surg. 2018 Mar;28(3):798-804. doi: 10.1007/s11695-017-2932-y.
3
Prevalence and associated factors of vitamin D deficiency after Roux-en-Y gastric bypass: a systematic review and meta-analysis.胃旁路术后维生素 D 缺乏症的患病率及相关因素:系统评价和荟萃分析。
Int J Surg. 2023 Dec 1;109(12):4273-4285. doi: 10.1097/JS9.0000000000000732.
4
Relationships of serum 25-hydroxyvitamin D, ionized calcium and parathyroid hormone after obesity surgery.肥胖症手术后血清 25-羟维生素 D、离子钙和甲状旁腺激素的关系。
Clin Endocrinol (Oxf). 2018 Mar;88(3):372-379. doi: 10.1111/cen.13531. Epub 2018 Jan 4.
5
Relationships Between Vitamin D Status and PTH over 5 Years After Roux-en-Y Gastric Bypass: a Longitudinal Cohort Study.Roux-en-Y 胃旁路术后 5 年维生素 D 状态与 PTH 的关系:一项纵向队列研究。
Obes Surg. 2020 Sep;30(9):3426-3434. doi: 10.1007/s11695-020-04582-5.
6
Rates of secondary hyperparathyroidism after bypass operation for super-morbid obesity: An overlooked phenomenon.超级病态肥胖患者旁路手术后继发性甲状旁腺功能亢进的发生率:一种被忽视的现象。
Surgery. 2017 Mar;161(3):720-726. doi: 10.1016/j.surg.2016.08.046. Epub 2016 Oct 18.
7
Primary hyperparathyroidism after Roux-en-Y gastric bypass.Roux-en-Y胃旁路术后的原发性甲状旁腺功能亢进症
Obes Surg. 2015 Apr;25(4):700-4. doi: 10.1007/s11695-014-1444-2.
8
Secondary hyperparathyroidism, vitamin D sufficiency, and serum calcium 5 years after gastric bypass and duodenal switch.胃旁路和十二指肠转位术后 5 年的继发性甲状旁腺功能亢进症、维生素 D 充足和血清钙。
Obes Surg. 2013 Mar;23(3):384-90. doi: 10.1007/s11695-012-0772-3.
9
Secondary Hyperparathyroidism Before and After Bariatric Surgery: a Prospective Study with 2-Year Follow-Up.减肥手术前后的继发性甲状旁腺功能亢进:一项为期2年随访的前瞻性研究。
Obes Surg. 2022 Apr;32(4):1141-1148. doi: 10.1007/s11695-022-05902-7. Epub 2022 Jan 20.
10
Secondary Hyperparathyroidism Among Bariatric Patients: Unraveling the Prevalence of an Overlooked Foe.肥胖症患者的继发性甲状旁腺功能亢进症:揭示被忽视的敌人的流行情况。
Obes Surg. 2021 Aug;31(8):3768-3775. doi: 10.1007/s11695-021-05495-7. Epub 2021 Jun 12.

引用本文的文献

1
APPLICATION VALUE OF DISSECTION PARATHYROIDECTOMY IN PATIENTS WITH CHRONIC KIDNEY DISEASE COMPLICATED BY REFRACTORY SECONDARY HYPERPARATHYROIDISM.解剖性甲状旁腺切除术在慢性肾脏病合并难治性继发性甲状旁腺功能亢进患者中的应用价值
Acta Endocrinol (Buchar). 2024 Jul-Sep;20(3):304-310. doi: 10.4183/aeb.2024.304. Epub 2025 May 23.
2
Continuous PPI Treatment After Gastric Bypass Increases the Risk of Pathological PTH Levels at 10 Years Postoperatively.胃旁路术后持续使用质子泵抑制剂治疗会增加术后10年出现病理性甲状旁腺激素水平的风险。
Obes Surg. 2025 Mar;35(3):941-945. doi: 10.1007/s11695-025-07692-0. Epub 2025 Jan 27.
3
Changes in Nutritional Outcomes After Roux-en-Y Gastric Bypass: A Systematic Review and Meta-Analysis.
Roux-en-Y 胃旁路术后营养结局的变化:系统评价和荟萃分析。
Obes Surg. 2024 Jun;34(6):2116-2129. doi: 10.1007/s11695-024-07232-2. Epub 2024 Apr 25.
4
Multiple micronutrient deficiencies as a long-term complication of bariatric surgery.多种微量营养素缺乏作为减肥手术的长期并发症
BMJ Case Rep. 2023 Dec 7;16(12):e254775. doi: 10.1136/bcr-2023-254775.